We only have this paper's title and publication details.
Read it at the sourceExperimental drug RGN6024 reduces viability in glioblastoma cell lines, suggesting a new brain-penetrant treatment option.
The effect of RGN6024 on the viability of glioblastoma cell lines
No takes yet. Share an insight, caveat, or question.
Patrón et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: